AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

CRISPR Therapeutics AG Director's Dealing 2017

Aug 2, 2017

30936_dirs_2017-08-01_d4fd9cb5-c749-42e6-9004-488b26392d72.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CRISPR Therapeutics AG (CRSP)
CIK: 0001674416
Period of Report: 2017-08-01

Reporting Person: Ho Tony W (See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned	0	Direct